tiprankstipranks
Advertisement
Advertisement
Merck price target raised to $180 from $155 at Wolfe Research
PremiumThe FlyMerck price target raised to $180 from $155 at Wolfe Research
3d ago
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
Premium
The Fly
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
4d ago
Merck & Company Soars on Breakthrough Cancer Vaccine Hopes
Premium
Weekend Updates
Merck & Company Soars on Breakthrough Cancer Vaccine Hopes
6d ago
Tempus AI price target raised to $80 from $70 at BTIG
PremiumThe FlyTempus AI price target raised to $80 from $70 at BTIG
8d ago
Merck price target raised to $175 from $145 at UBS
Premium
The Fly
Merck price target raised to $175 from $145 at UBS
8d ago
RBC downgrades Merck on ‘unprecedented valuation’ after vaccine data
Premium
The Fly
RBC downgrades Merck on ‘unprecedented valuation’ after vaccine data
8d ago
Early notable gainers among liquid option names on August 19th
PremiumThe FlyEarly notable gainers among liquid option names on August 19th
9d ago
Video: Moderna skyrockets after cancer vaccine shows promise in Phase 3 trial
Premium
The Fly
Video: Moderna skyrockets after cancer vaccine shows promise in Phase 3 trial
9d ago
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
Premium
The Fly
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
9d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100